Microbix Biosystems Inc.
MBX.TO
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -837.20K | -1.08M | -1.19M | 14.40K | 612.20K |
| Total Depreciation and Amortization | 302.30K | 317.10K | 321.50K | 298.30K | 310.70K |
| Total Amortization of Deferred Charges | 25.00K | 25.30K | -- | -- | -- |
| Total Other Non-Cash Items | 230.60K | 201.50K | 213.10K | 192.40K | 211.60K |
| Change in Net Operating Assets | -1.59M | 592.10K | -737.70K | 168.60K | -568.20K |
| Cash from Operations | -1.87M | 61.00K | -1.39M | 673.60K | 566.30K |
| Capital Expenditure | -122.20K | -112.00K | -140.70K | -170.90K | -145.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -122.20K | -112.00K | -140.70K | -170.90K | -145.10K |
| Total Debt Issued | -- | 359.30K | -- | -- | -- |
| Total Debt Repaid | -68.70K | -68.70K | -52.90K | -1.22M | -73.20K |
| Issuance of Common Stock | -- | 0.00 | -- | 2.74M | 79.60K |
| Repurchase of Common Stock | -173.70K | -208.30K | -266.70K | -744.30K | -511.30K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -173.90K | 59.70K | -230.90K | 536.00K | -360.70K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | 0.00 | -- | 0.00 | -- |
| Net Change in Cash | -2.16M | 8.60K | -1.76M | 1.04M | 60.50K |